To avoid confounding effects from tumour growth or lysis, we conducted all experiments in non-tumour-bearing wild-type BALB/c mice, where CD19-CAR T cells target CD19 on normal B cells.45 Control mice received syngeneic T cells which underwent mock transduction without viral vector (‘mock T cells’). The gene discussed is CD19; the disease is neoplasm.